Truist Financial
KURA icon

Truist Financial’s Kura Oncology KURA Stock Holding History

Truist Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,378
Closed -$229K – 2764
2021
Q4 		$229K Hold
16,378
– – ﹤0.01% 2519
2021
Q3 		$307K Sell
16,378
-47
-0.3% -$886 ﹤0.01% 2341
2021
Q2 		$342K Sell
16,425
-24
-0.1% -$596 ﹤0.01% 2291
2021
Q1 		$465K Hold
16,449
– – ﹤0.01% 2008
2020
Q4 		$537K Hold
16,449
– – ﹤0.01% 1815
2020
Q3 		$504K Hold
16,449
– – ﹤0.01% 1720
2020
Q2 		$268K Sell
16,449
-14
-0.1% -$202 ﹤0.01% 2026
2020
Q1 		$163K Hold
16,463
– – ﹤0.01% 2172
2019
Q4 		$227K Buy
+16,463
New +$244K ﹤0.01% 2298

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Truist Financial's KURA Position: Q1 2022 in Review

Truist Financial sold out of Kura Oncology (KURA) in Q1 2022, closing a stake of 16,378 shares — an estimated $229K sold.

Truist Financial first reported a position in KURA in Q4 2019 and held it in 9 quarters. The position peaked at $537K in Q4 2020. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

  • Truist Financial reported no remaining Kura Oncology position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 16,378 Kura Oncology shares in Q1 2022, an estimated $229K.
  • Truist Financial first reported a position in Kura Oncology in Q4 2019 and held it in 9 quarters.
  • Truist Financial's Kura Oncology position peaked at $537K in Q4 2020.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.